Literature DB >> 20945614

Ataxia-telangiectasia in a patient presenting with hyper-immunoglobulin M syndrome.

A Aghamohammadi1, K Imai, K Moazzami, H Abolhassani, M Tabatabaeiyan, N Parvaneh, R Nasiri Kalmarzi, N Nakagawa, K Oshima, O Ohara, S Nonoyama, N Rezaei.   

Abstract

Ataxia-telangiectasia (AT) and hyper-immunoglobulin M (HIGM) syndrome are both primary immunodeficiency diseases caused by different genetic defects. While a small proportion of AT patients have increased serum immunoglobulin (Ig) M concentrations during the course of a disease, a high level of IgM at onset is rare. We report the case of an 8-year-old girl who had experienced recurrent respiratory infection, cutaneous abscesses, and hepatosplenomegaly since the age of 2 years. She was diagnosed with HIGM based on the results of immunological studies, including low IgG and IgA levels and raised serum IgM concentrations. However, at the age of 4 years, a neurological examination revealed gait disturbance and telangiectatic lesions on the conjunctiva; therefore, a diagnosis of AT was suggested. In spite of regular intravenous immunoglobulin infusions and antimicrobial prophylaxis, the patient experienced several episodes of respiratory infection and eventually died of respiratory failure at the age of 8 years. Further molecular analysis revealed a novel homozygous missense mutation in exon 53 (c.8250C>T, p.2622Ala>Val) of the ATM gene. Patients with AT and the HIGM phenotype may not develop clinical characteristics of AT for some time. While patients with AT and increased serum IgM levels could have a considerably more severe disease course and a shorter survival, IgM levels could be considered a prognostic factor.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20945614

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN: 1018-9068            Impact factor:   4.333


  13 in total

1.  Ataxia Telangiectasia Masquerading as Hyper IgM Syndrome.

Authors:  Amit Rawat; Kohsuke Imai; Deepti Suri; Anju Gupta; Swapnil Bhisikar; Biman Saikia; Ranjana W Minz; Shobha Sehgal; Surjit Singh
Journal:  Indian J Pediatr       Date:  2015-07-30       Impact factor: 1.967

Review 2.  Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases.

Authors:  Sayna Norouzi; Asghar Aghamohammadi; Setareh Mamishi; Sergio D Rosenzweig; Nima Rezaei
Journal:  J Infect       Date:  2012-03-16       Impact factor: 6.072

3.  Fatal outcome despite full lympho-hematopoietic reconstitution after allogeneic stem cell transplantation in atypical ataxia telangiectasia.

Authors:  Sujal Ghosh; Friedhelm R Schuster; Vera Binder; Tim Niehues; Stephan E Baldus; Peter Seiffert; Hans-Jürgen Laws; Arndt Borkhardt; Roland Meisel
Journal:  J Clin Immunol       Date:  2012-02-23       Impact factor: 8.542

4.  Ataxia Telangiectasia Diagnosed on Newborn Screening-Case Cohort of 5 Years' Experience.

Authors:  Amarilla B Mandola; Brenda Reid; Raga Sirror; Rae Brager; Peter Dent; Pranesh Chakroborty; Dennis E Bulman; Chaim M Roifman
Journal:  Front Immunol       Date:  2019-12-20       Impact factor: 7.561

5.  Vasculitis in a Child With the Hyper-IgM Variant of Ataxia-Telangiectasia.

Authors:  Anna K Meyer; Mindy Banks; Tibor Nadasdy; Jennifer J Clark; Rui Zheng; Erwin W Gelfand; Jordan K Abbott
Journal:  Front Pediatr       Date:  2019-10-24       Impact factor: 3.418

6.  Granulomatous Liver Disease in Ataxia-Telangiectasia With the Hyper-IgM Phenotype: A Case Report.

Authors:  Aleksandra Szczawińska-Popłonyk; Lidia Ossowska; Katarzyna Jończyk-Potoczna
Journal:  Front Pediatr       Date:  2020-11-19       Impact factor: 3.418

7.  Variable Abnormalities in T and B Cell Subsets in Ataxia Telangiectasia.

Authors:  Tannaz Moeini Shad; Bahman Yousefi; Parisa Amirifar; Samaneh Delavari; William Rae; Parviz Kokhaei; Hassan Abolhassani; Asghar Aghamohammadi; Reza Yazdani
Journal:  J Clin Immunol       Date:  2020-10-14       Impact factor: 8.317

8.  Elevated IgM levels as a marker for a unique phenotype in patients with Ataxia telangiectasia.

Authors:  Alexander Krauthammer; Avishay Lahad; Lior Goldberg; Ifat Sarouk; Batia Weiss; Raz Somech; Michalle Soudack; Itai M Pessach
Journal:  BMC Pediatr       Date:  2018-06-04       Impact factor: 2.125

9.  Clinical, Immunological, and Functional Characterization of Six Patients with Very High IgM Levels.

Authors:  Vera Gallo; Emilia Cirillo; Rosaria Prencipe; Alessio Lepore; Luigi Del Vecchio; Giulia Scalia; Vincenzo Martinelli; Gigliola Di Matteo; Carol Saunders; Anne Durandy; Viviana Moschese; Antonio Leonardi; Giuliana Giardino; Claudio Pignata
Journal:  J Clin Med       Date:  2020-03-17       Impact factor: 4.241

10.  Dystonia in Ataxia Telangiectasia: A Case Report with Novel Mutations.

Authors:  Majid Zaki-Dizaji; Mohammad Tajdini; Fatemeh Kiaee; Hossein Shojaaldini; Reza Shervin Badv; Hassan Abolhassani; Asghar Aghamohammadi
Journal:  Oman Med J       Date:  2020-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.